Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IGC Pharma (IGC) Gross Profit (2016 - 2025)

IGC Pharma (IGC) has disclosed Gross Profit for 16 consecutive years, with $99000.0 as the latest value for Q3 2025.

  • Quarterly Gross Profit fell 50.0% to $99000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $511000.0 through Sep 2025, down 23.16% year-over-year, with the annual reading at $619000.0 for FY2025, 15.55% down from the prior year.
  • Gross Profit for Q3 2025 was $99000.0 at IGC Pharma, down from $154000.0 in the prior quarter.
  • The five-year high for Gross Profit was $255000.0 in Q2 2023, with the low at $26000.0 in Q2 2021.
  • Average Gross Profit over 5 years is $119368.4, with a median of $133000.0 recorded in 2023.
  • The sharpest move saw Gross Profit soared 446.15% in 2022, then plummeted 50.0% in 2025.
  • Over 5 years, Gross Profit stood at $62000.0 in 2021, then surged by 64.52% to $102000.0 in 2022, then soared by 30.39% to $133000.0 in 2023, then dropped by 21.8% to $104000.0 in 2024, then decreased by 4.81% to $99000.0 in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $99000.0, $154000.0, and $154000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.